Clinical trials

  • ETANERCEPT for Giant cell arteritis
  • DATOPOTAMAB DERUXTECAN for Advanced or metastatic non-small cell lung cancer
  • ESKETAMINE for Major depressive disorder
  • LITIFILIMAB for Subacute cutaneous lupus erythematosus | Chronic cutaneous lupus erythematosus
  • Ocrelizumab for Multiple sclerosis
  • KETAMINE for Major depressive disorder with current severe major depressive episode
  • VINCRISTINE SULFATE for Richter's syndrome|Diffuse large B-cell lymphoma (Richter transformation)
  • IANALUMAB for Systemic lupus erythematosus
  • CILTACABTAGENE AUTOLEUCEL for Multiple myeloma (relapsed; lenalidomide-refractory)
  • mirvetuximab soravtansine for Recurrent ovarian cancer with high folate receptor-alpha expression
  • DATOPOTAMAB DERUXTECAN for Triple negative breast cancer | Hormone receptor-low HER2-negative breast cancer
  • AMLITELIMAB for Atopic dermatitis